Objectives: Polycystic ovary syndrome one of the major Endocrine and reproductive abnormality which represent the largest unique young women at high risk for development of premature atherosclerotic heart disease. The Metabolic disturbances associated with PCOS like Insulin resistance, hyperandrogenism, and hypertension may adversely accelerate the cardiovascular risk profile in these young Women. With this background, a case control study was undertaken to evaluate the levels of Traditional and Novel CV risk markers in PCOS women compared to healthy controls. Methods: Fasting blood Glucose, Insulin, Insulin resistance (homeostasis model assessment, HOMA-IR), Testosterone, Lipid levels, Homocysteine, C- reactive protein and Uric acid levels were determined in Fourty diagnosed PCOS women and healthy age matched controls. All biochemical analysis was done using commercial enzymatic kits. Results: Testosterone the main component of PCOS, HOMA-IR were significantly (p__ampersandsignlt;0.05) higher in PCOS women than controls. Insulin, Total cholesterol, TGL, HDL, LDL levels were also significantly (p__ampersandsignlt;0.05) higher in PCOS women and the Novel CV markers Homocysteine, CRP, Uric acid were significantly (p__ampersandsignlt;0.05) elevated in PCOS women compared to controls. Conclusion: Both Traditional and Novel CV risk markers were significantly elevated in PCOS women indicating early onset cardiovascular risk in these young women. Hence, correction and routine screening for these parameters helps in early identification of cardiovascular risk and can prevent the development of endothelial dysfunction, which is a reversible early event in atherosclerosis and appropriate treatment should be aimed to control these parameters.